Delivery Order SPE2DB22D1106-SPE2DB24FFBG4
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$42K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $15,594.00, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 2, 2024 and was awarded on August 1, 2024. This delivery...
This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $83,437.62. This is a firm fixed-price delivery order contract with a period of performance ending on February 28, 2024. The contract was awarded on February 27, 2024, with no set-aside designation,...
This federal contract award, valued at $6,930.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Gonal-F RFF Redi-Ject 900 unit 1.5ml, a pharmaceutical product, with a completion date of June 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December...
The federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $15,942.66 and has an ultimate completion date of September 10, 2021. This award is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,237.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 900 units of GONAL-F RFF REDI-JECT 1.5ML medication. This delivery order contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides a wide range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a pharmaceutical product, with a ceiling value of $1,097.48 and a period of performance through June 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,097.52 and a period of performance through May 6, 2025. This contract is not a set-aside and was awarded as part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific medication - Ganirelix Acetate 250 mcg/0.5 ml. The contract, valued at $7,291.08, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary logistics provider for the Department of Defense (DoD). The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,735.56 Firm Fixed Price delivery order is for the drug Ganirelix Acetate 250 MCG/0.5 ML 0.5ML, with a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $18,867.06 and is a Firm Fixed Price delivery order. It is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC enables Amerisourcebergen to deliver a...